Darren S Cline Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Darren S Cline.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Darren S Cline. Darren S Cline is a EVP, Commercial in SEATTLE GENETICS INC /WA ($SGEN) and an Executive Vice President in SEATTLE GENETICS INC /WA ($SGEN) and a See Remarks in SEATTLE GENETICS INC /WA ($SGEN) and a SVP, Commercial in SEATTLE GENETICS INC /WA ($SGEN) and a Director in STEMLINE THERAPEUTICS INC ($STML) and a U.S. Chief Commercial Officer in GW PHARMACEUTICALS PLC ($GWPH).
Address: 21823 30TH DRIVE SE BOTHELL 98021 WA
Companies in which Darren S Cline is an Insider
GW PHARMACEUTICALS PLC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Darren S Cline: U.S. Chief Commercial Officer
Holdings: 0 shares
Latest Transaction: May 07 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Seagen Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Darren S Cline: See Remarks, EVP, Commercial, Executive Vice President, SVP, Commercial
Holdings: 72,556 shares
Current Value: $4,410,679
Latest Transaction: Nov 30 2018
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
STEMLINE THERAPEUTICS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Darren S Cline: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 10 2020
$STML Market Capitalization: $118.68M
$STML Previous Close: $6.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Darren S Cline
Sentiment: All, GWPH, SGEN, STML
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 07 2021 | GWPH | GW PHARMACEUTICALS ... | Cline Darren S | U.S. Chief Commerci ... | Option Exercise | D | 0.00 | 75,024 | 128 | 0 | |
| May 07 2021 | GWPH | GW PHARMACEUTICALS ... | Cline Darren S | U.S. Chief Commerci ... | Option Exercise | D | 0.00 | 46,896 | 80 | 0 | |
| May 07 2021 | GWPH | GW PHARMACEUTICALS ... | Cline Darren S | U.S. Chief Commerci ... | Option Exercise | D | 0.00 | 177,180 | 301 | 0 | |
| May 07 2021 | GWPH | GW PHARMACEUTICALS ... | Cline Darren S | U.S. Chief Commerci ... | Option Exercise | D | 0.00 | 106,320 | 181 | 0 | |
| May 07 2021 | GWPH | GW PHARMACEUTICALS ... | Cline Darren S | U.S. Chief Commerci ... | Option Exercise | D | 0.00 | 98,040 | 167 | 0 | |
| May 07 2021 | GWPH | GW PHARMACEUTICALS ... | Cline Darren S | U.S. Chief Commerci ... | Option Exercise | D | 0.00 | 22,068 | 38 | 0 | |
| May 07 2021 | GWPH | GW PHARMACEUTICALS ... | Cline Darren S | U.S. Chief Commerci ... | Option Exercise | D | 15.30 | 54,192 | 829,230 | 0 |